🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Immune Related Adverse Events

Checkpoint Inhibitor-induced Liver Injury NCT04476563n/a1 site📍 Nottingham University of Nottingham · Tests: Obtaining biological samples Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial NCT06470971Phase 21 site📍 Columbus Yuanquan Yang · Tests: Anti-PD-L1 Monoclonal Antibody, Anti-PD1 Monoclonal Antibody, Biopsy, Biospecimen Collection, Bone Scan Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer NCT06613165n/a1 site📍 Xi'an Xijing Hospital Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients NCT07130981n/a1 site📍 Ankara Hacettepe University Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment NCT05813418NA1 site📍 Amiens Centre Hospitalier Universitaire, Amiens · Tests: blood retriewal Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia NCT05512169n/a2 sites📍 New Delhi📍 Puducherry University of Geneva, Switzerland Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing NCT06406114Phase 26 sites📍 Scottsdale📍 San Francisco📍 Boston Massachusetts General Hospital · Tests: Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, a… IMMUNO-FIT Observational Study NCT07354971n/a1 site📍 Southampton University Hospital Southampton NHS Foundation Trust · Tests: Observational Study - No Study Intervention Montreal Immune-Related Adverse Events (MIRAE) Study NCT05139706n/a1 site📍 Montreal Sir Mortimer B. Davis - Jewish General Hospital High Dimensional Analysis of Immune Cells in Pediatric Patients NCT05820802n/a1 site📍 Seoul Seoul National University Hospital Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository NCT06789601Phase 1, Phase 22 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Informatics system for eligibility monitoring, Standard eligibility monitoring Drug Reactions Sampling (COLLECTIONTOXIDERMIES) NCT03659227n/a1 site📍 Créteil Assistance Publique - Hôpitaux de Paris Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With Cancer NCT06337695Phase 2, Phase 32 sites📍 Calgary📍 Edmonton AHS Cancer Control Alberta · Tests: Vedolizumab, Placebo Brodalumab in the Treatment of Immune-Related Adverse Events NCT06673329Phase 11 site📍 New York Brian Henick, MD · Tests: Brodalumab, CT scan Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) NCT05663775Phase 21 site📍 Edmonton AHS Cancer Control Alberta · Tests: Mesalamine Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer NCT06977594NA1 site📍 Seoul Seoul National University Hospital · Tests: Proactive immune tolerance induction, Standard Treatment, Paclitaxel and carboplatin, Standard premedication (20 mg), R… Post-market Safety Study of LUMISIGHT NCT07572162n/a2 sites📍 Mobile📍 Palo Alto Lumicell, Inc. Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis NCT06860542Phase 21 site📍 Calgary AHS Cancer Control Alberta · Tests: Arm 2- Budesonide (Pulmicort® Turbuhaler®) + Usual care, Arm 1- Usual care Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients NCT04840355n/a1 site📍 Beijing Guohui Li · Tests: Sintilimab Injection Abatacept in Immune Checkpoint Inhibitor Myocarditis NCT05335928Phase 331 sites📍 Los Angeles📍 Los Angeles📍 Washington D.C. Massachusetts General Hospital · Tests: Abatacept plus, Placebo Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients NCT07249060n/a1 site📍 Pamplona Hospital Universitario Araba · Tests: Immune Checkpoint Inhibitors ATROPOS: Survival Analysis of ICI-associated Myocarditis NCT07633587n/a1 site📍 Paris Groupe Hospitalier Pitie-Salpetriere Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma NCT07443514NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Structured Neurocognitive Assessment Battery, Psychometric Questionnaires, CSF Biomarker Analysis PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer NCT07775820n/a5 sites📍 Guangzhou📍 Guangzhou📍 Shenzhen Nanfang Hospital, Southern Medical University · Tests: PD-L1 Inhibitor Rechallenge, PD-1 Inhibitor Rechallenge, No Immune Checkpoint Inhibitor Rechallenge Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma NCT07430579NA1 site📍 Jinan The Second Hospital of Shandong University · Tests: adebrelimab combined with chemotherapy Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects NCT04242095n/a629 sites📍 Anchorage📍 Anchorage📍 Anchorage Alliance for Clinical Trials in Oncology · Tests: Biospecimen Collection, Medical Chart Review Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome NCT04330118n/a11 sites📍 Arras📍 Boulogne-sur-Mer📍 Créteil University Hospital, Lille Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial) NCT03711110NA14 sites📍 Santiago de Compostela📍 Galdakao📍 Barcelona Fundación Instituto de Estudios de Ciencias de la Salud de … · Tests: Intensive cardiovascular monitoring, No intervention The Effect of Serum Ferritin in irAE NCT06702566NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: PD-1 and PD-L1 inhibitor, Targeted drugs, chemotherapy drugs Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma NCT07680556NA2 sites📍 Arnhem📍 Nijmegen Radboud University Medical Center · Tests: HIIT
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy